FantasticSearch

Additional objectives of the Innovative Health Joint Undertaking

1. In addition to the objectives set out in Articles 4 and 5, the Innovative Health Initiative Joint Undertaking shall reach the following general objectives by 2030:

(a) contribute towards the creation of a Union-wide health research and innovation ecosystem that facilitates translation of scientific knowledge into innovations, in particular by launching at least 30 large-scale cross-sectoral projects, focusing on health innovations;

(b) foster the development of safe, effective, people-centred and cost-effective innovations that respond to strategic unmet public health needs, by exhibiting, in at least five examples, the feasibility of integrating health care products or services, with demonstrated suitability for uptake by health care systems. The related projects should address the prevention, diagnosis, treatment or management of diseases affecting the Union population, including contribution to Europe’s Beating Cancer Plan;

(c) drive cross-sectoral health innovation for a globally competitive European health industry, and contribute to reaching the objectives of the new Industrial Strategy for Europe and the Pharmaceutical Strategy for Europe.

2. The Innovative Health Initiative Joint Undertaking shall also have the following specific objectives:

(a) contribute towards a better understanding of the determinants of health and priority disease areas;

(b) integrate fragmented health research and innovation efforts bringing together health industry sectors and other stakeholders, focusing on unmet public health needs, to enable the development of tools, data, platforms, technologies and processes for improved prediction, prevention, interception, diagnosis, treatment and management of diseases, meeting the needs of end-users;

(c) demonstrate the feasibility of people-centred integrated health care solutions;

(d) exploit the full potential of digitalisation and data exchange in health care;

(e) enable the development of new and improved methodologies and models for a comprehensive assessment of the added value of innovative and integrated health care solutions.